|

WBC100 QD Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Hangzhou Weben Pharma Co., Ltd1

Indications

  • C-Myc1
  • Relapsed Acute Myelogenous Leukemia1
  • Adult Acute Myeloid Leukemia1
  • Refractory Acute Myeloid Leukemia1
  • Hematologic Malignancy1

Other1 trial

Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.